Regenxbio (NASDAQ:RGNX) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Regenxbio beat estimated earnings by 0.65%, reporting an EPS of $-1.53 versus an estimate of $-1.54.
Revenue was down $3.08 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.15 which was followed by a 8.49% increase in the share price the next day.
Here’s a look at Regenxbio’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.23 | -1.46 | -1.53 | -1.32 |
| EPS Actual | -1.38 | -1.75 | -1.58 | -1.58 |
| Revenue Estimate | 37.45M | 30.81M | 26.79M | 29.21M |
| Revenue Actual | 31.34M | 26.51M | 32.65M | 22.22M |
To track all earnings releases for Regenxbio visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
